Liposomal Bupivacaine in Vaginal Hysterectomy
NCT03907033
·
clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
28
Enrollment
OTHER
Sponsor class
Stopped
Insufficient funding to continue with study activities
Conditions
Vaginal Hysterectomy
Interventions
DRUG:
Liposomal bupivacaine
DRUG:
Bupivacaine Hydrochloride
Sponsor
Mayo Clinic
Collaborators
[object Object]